tiprankstipranks
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
US Market
Want to see LFCR full AI Analyst Report?

Lifecore Biomedical (LFCR) Financial Statements

152 Followers

Lifecore Biomedical Financial Overview

Lifecore Biomedical's market cap is currently $165.79M. The company's EPS TTM is $-1.03; its P/E ratio is -4.80; Lifecore Biomedical is scheduled to report earnings on August 6, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25May 25May 24Aug 23May 22
Income Statement
Total Revenue$ 129.46M$ 128.87M$ 128.26M$ 103.27M$ 111.27M
Gross Profit$ 40.61M$ 40.30M$ 41.85M$ 27.98M$ 39.07M
Operating Income$ -1.26M$ -17.25M$ -8.84M$ -21.80M$ -11.79M
EBITDA$ 8.24M$ -8.81M$ 35.60M$ -33.17M$ 12.84M
Net Income$ -30.79M$ -38.72M$ 12.01M$ -99.56M$ -116.72M
Balance Sheet
Cash & Short-Term Investments$ 17.47M$ 8.27M$ 8.46M$ 19.09M$ 991.00K
Total Assets$ 232.18M$ 239.34M$ 253.96M$ 253.54M$ 274.70M
Total Debt$ 142.61M$ 130.82M$ 133.57M$ 112.62M$ 247.78M
Net Debt$ 125.14M$ 122.56M$ 125.11M$ 93.53M$ 246.79M
Total Liabilities$ 246.38M$ 238.01M$ 242.65M$ 257.77M$ 186.88M
Stockholders' Equity$ -14.20M$ 1.34M$ 11.31M$ -4.23M$ 87.82M
Cash Flow
Free Cash Flow$ 6.23M$ -13.62M$ -18.14M$ -38.92M$ -52.53M
Operating Cash Flow$ 12.57M$ -206.00K$ 257.00K$ -17.44M$ -22.59M
Investing Cash Flow$ 10.81M$ -6.42M$ -18.39M$ -4.81M$ 79.96M
Financing Cash Flow$ -7.59M$ 6.42M$ 7.51M$ 39.70M$ -57.02M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

Lifecore Biomedical Debt to Assets

Lifecore Biomedical Cash Flow

Lifecore Biomedical Forecast EPS vs Actual EPS